Published by Manila Times
THE Securities and Exchange Commission (SEC) has cleared the P3.5-billion preferred shares offering of tech manufacturer, Cirtek Holdings Philippines Corp.
The commission on Wednesday said it has approved Cirtek's registration statement in its meeting on October 26.
The registration statement covers 50 million preferred B-2 Subseries C and D shares priced at P50 apiece, with an oversubscription option of up to 20 million shares.
Cirtek looks to raise up to P3.44 billion from the offer, which will refinance the company's existing debt, partially pay its maturing debt and fund its capital expenditures and equipment and the working capital of its subsidiaries.
According to the SEC, Cirtek's offer period will run from November 25 to December 3, while listing on the main board of the stock exchange is eyed on December 10.
PSE OKs Medilines first IPO PNB Capital and Investment Corp. was assigned as the sole issue manager, lead underwriter and sole bookrunner for the transaction.
Cirtek's net income rose by 60 percent to $8 million in the first six months of the year from $5 million in the same period last year.
Shares of Cirtek were up 6 centavos or 1.39 percent to close at P4.37 each on Wednesday.
Dec 17, 2020
Cirtek Holdings Philippines Corp. (“Cirtek”), appoints BDO Unibank, Inc. (“BDO”) a
Read moreAug 17, 2021
Published by Business World
CIRTEK Holdings Philippines Corp. has listed 249.44 million common shares in the local bourse, and will issue bonus detachable warrants of the same number, the company said on Monday.
In a press release, Cirtek Holdings said that the common shares sold through a stock rights offer are at an offer price of P5.50 per entitlement right each. The company set the ratio at one entitlement right for every 1.68 common shares.
Meanwhile, the company said that it is also issuing bonus detachable warrants which are free-of-charge to the investor. “[The warrants] shall be issue...
Read moreJul 08, 2020
Quintel USA, Inc., a subsidiary of Cirtek Holdings Philippines Corp (CHPC)
Read more